Related Experiment Video
Updated: May 28, 2025

The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
Challenges and ongoing initiatives towards better integrated EU scientific advice
Iordanis Gravanis1, Michael Berntgen1, Spiros Vamvakas1
1European Medicines Agency, Amsterdam, Netherlands.
Abstract:
Scientific advice is the main avenue for clarification of EU regulators' scientific evidence requirements during medicines development. There are multiple avenues for seeking scientific advice in the EU with partially overlapping scope which creates room for divergence and contradictions; simplification and better integration among them could help harmonize EU regulators' requirements. Interaction with other decision makers providing advice along the lifecycle of medicines and other healthcare solutions reduces development uncertainties. The proposal for a new EU pharmaceutical legislation solidifies existing advice mechanisms and creates new avenues for enhanced integration of development support.
Related Concept Videos
Sustainable Development
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
What is Biodiversity?
International Nursing Organizations I
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...

